Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
19.74
-0.08 (-0.40%)
At close: Aug 15, 2025, 10:04 AM

Castle Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
332.07M 219.79M 137.04M 94.08M
Cost of Revenue
60.2M 44.98M 32.01M 15.82M
Gross Profit
271.86M 174.81M 105.03M 78.26M
Operating Income
8.67M -67.98M -91.14M -40.08M
Interest Income
12.92M 10.62M 3.97M 68K
Pretax Income
21.56M -57.37M -68.9M -40.01M
Net Income
18.25M -57.47M -67.14M -31.29M
Selling & General & Admin
200.05M 180.15M 143M 86.74M
Research & Development
52.04M 53.62M 44.9M 29.65M
Other Expenses
11.11M 9.01M 8.27M 1.96M
Operating Expenses
263.19M 242.78M 196.17M 118.34M
Interest Expense
577K 11K 17K 1K
Selling & Marketing Expenses
123.47M 113.66M 86.61M n/a
Cost & Expenses
323.4M 287.76M 228.18M 134.16M
Income Tax Expense
3.32M 101K -1.77M -8.72M
Shares Outstanding (Basic)
27.78M 26.8M 26.05M 25.14M
Shares Outstanding (Diluted)
29.25M 26.8M 26.05M 25.14M
EPS (Basic)
0.66 -2.14 -2.58 -1.24
EPS (Diluted)
0.62 -2.14 -2.58 -1.24
EBITDA
38.14M -45.02M -58.34M -36.6M
EBIT
22.14M -57.35M -68.89M -40.01M
Depreciation & Amortization
16M 12.33M 10.54M 3.41M